November 2016 definition

November 2016. Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE: OXB), a leading gene and cell therapy group, today announces it has entered into a strategic alliance with Orchard Therapeutics (“Orchard”), a biotechnology company dedicated to bringing transformative ex-vivo stem cell based gene therapies to patients with serious and life-threatening orphan diseases. As part of the agreement the Group will develop and supply lentiviral vectors used by Orchard for the manufacture of ex-vivo gene therapy products in primary immune deficiency disorders and inherited metabolic disorders, including adenosine deaminase severe combined immunodeficiency (ADA-SCID), Mucopolysaccharidosis-IIIA (MPS-IIIA or ▇▇▇▇▇▇▇▇▇▇ Syndrome type A) and undisclosed follow-on indications. Orchard will lead the global clinical development and commercialisation of collaboration programs in Europe, the United States and in other regions. Under the terms of the collaboration and licence agreement, Oxford BioMedica will receive a 1.95% equity stake in Orchard and will be entitled to royalties on future sales of products covered by the collaboration. The Group will provide process development services and manufacture clinical and commercial GMP-grade lentiviral vectors for Orchard. The process development arrangements include performance-related incentives through which Oxford BioMedica could receive a further 1.95% equity stake in Orchard. The Group has also granted an exclusive intellectual property licence to Orchard for collaboration programmes. ▇▇▇▇ ▇▇▇▇▇▇, Chief Executive Officer of Oxford BioMedica, commented: “We are delighted to initiate a Strategic Alliance with Orchard Therapeutics and look forward to working with them to develop and launch much needed treatments for patients in desperate need of better treatment options. The alliance combines Oxford BioMedica’s world-leading capabilities in lentiviral vector process development and bioprocessing expertise with Orchard’s expertise in the development and commercialisation of gene therapies for orphan diseases. This further demonstrates Oxford BioMedica’s position as a “go to” partner for companies and academic institutions working with lentiviral vector based products.”
View Source
November 2016. The UCDP GED data lists two battle-related FARC deaths on this day. This was shortly before the two sides signed the revised peace agreement. The circumstances surrounding this event are contested. FARC chief negotiator ▇▇▇▇ ▇▇▇▇▇▇▇ claimed that the two were on their way to a demobilization zone, but the army stated that the fighters were 69 km from such a zone and were involved in criminal activities (see ▇▇▇▇ 2016; ICG 2016c). Appendix Chapter Seven Survival curves for alternative fatality thresholds
View Source

Examples of November 2016 in a sentence

  • The following statements regarding the calculation of the Sentencing Guidelines are based on the Guidelines Manual currently in effect, namely the November 2016 Guidelines Manual.

  • The information is based on the securities, exchange control and other laws in effect in the respective countries as of November 2016.

  • C-211-H002 DRY-DOCK CERTIFICATION (NAVSEA) (OCT 2018) The dry-docking of all vessels shall be accomplished in dry docks certified in accordance with MIL-STD-1625D(SH) dated 27 August 2009 as invoked by NAVSEA Standard Item 009-01 dated 18 November 2016.

  • By: /s/ Xiaobo An Name: Xiaobo An Title: Legal Representative (Seal of the Company) Date: 1st November, 2016 Company Name: Hexin E-Commerce Co., Ltd.

  • Except as specifically amended as set forth herein, each term and condition of the November 2016 Notes shall continue in full force and effect.

  • The Department for Communities and Local Government in its letter dated 23 November 2016 confirmed that the Constituent Authorities have been granted permission for each Constituent Authority to continue to collaborate with every other Constituent Authority to form a pool of assets in respect of each of their respective funds under the LGPS.

  • Effective with hours worked in October 2016, payable in November 2016, an additional supplemental contribution of twenty and 7/10 cents ($0.207) per contribution-eligible hour.

  • Sick Leave and Personal Leave shall be governed by Section 250.08 and Section 250.09 of the “Codified Ordinances of Trenton, Ohio” that took effect in November 2016.

  • From and after such effectiveness, any reference to the November 2016 Notes shall be deemed to be a reference to the November 2016 Notes, as amended hereby.

  • This Amendment shall form a part of the November 2016 Notes for all purposes, and each holder of November 2016 Notes shall be bound hereby.